Submit Your Paper

PLoS wants to publish your clinical trials research!

PLoS Hubs collect together research from across many open-access journals, and do not accept submissions directly. You should continue to submit your work to the PLoS journal that best suits your needs. If you submit your clinical trials article to PLoS ONE it will automatically appear, upon publication, in the PLoS Hub for Clinical Trials. If you submit your work to another PLoS journal a link to the paper will be provided on the PLoS Hub homepage, and the article will be fully incorporated into the PLoS Hub in the coming months.

All PLoS journals are open-access, so whichever journal you choose, anyone interested in your work will be able to find it, read it, print it, distribute it, and build on it.

Which journal is right for your clinical trials research?

PLoS ONE is a rapid, efficient, and economical system for the publication of peer-reviewed research in all areas of science and medicine. It provides a unique forum for community dialogue using the full potential of the Web to accelerate scientific progress.

PLoS Medicine is an international, multidisciplinary medical journal publishing outstanding studies that substantially enhance the understanding of human health and disease. PLoS Medicine aims to promote translation of basic research into clinical investigation, and of clinical evidence into practice. PLoS Medicine encourages papers that cross disciplines. The current ISI impact factor for PLoS Medicine is 13.8.

PLoS Neglected Tropical Diseases will be the first open-access journal devoted to neglected tropical diseases (NTDs). The journal will publish high-quality, peer-reviewed research on all scientific, medical, and public health aspects of these forgotten diseases affecting the world�s forgotten people. Launching 2007.

PLoS Pathogens. From molecules to physiology, PLoS Pathogens publishes important new ideas on bacteria, fungi, parasites, prions, and viruses that contribute to our understanding of the biology of pathogens and pathogen-host interactions. The current ISI impact factor for PLoS Pathogens is 6.1.